[177Lu]Lu-DPI-4452

N/A

Report date: 2025/11/20 13:28:21
NME

Base Information

Drug Name[177Lu]Lu-DPI-4452
Drug Alias NameLutenium-177 DPI 4452[177Lu]Lu-DPI-4452Debio 0228ITM-913BP-4452 +[6] 
ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionAnti-Carbonic anhydrase IX
TargetsCarbonic anhydrase IX
Therapy Area/IndicationsUrinary Bladder NeoplasmsHead and Neck NeoplasmsColorectal Neoplasms +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaFrance
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator Companies3B Pharmaceuticals GmbH
China Registration ClassN/A

Develop Information

Active CompaniesITM Oncologics GmbH3B Pharmaceuticals GmbH
Inactive CompaniesN/A
Active IndicationsUrinary Bladder NeoplasmsHead and Neck NeoplasmsColorectal Neoplasms +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A